The Valley Desk

NCT05484622 · Interventional trial

Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma

Overall registry status Active not recruiting

Phase 1

Conditions Astrocytoma, Oligodendroglioma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov